Knight Therapeutics Ranks No. 345 on Canada’s Top Growing Companies…

Event summary

Knight Therapeutics ranked No. 345 on The Globe and Mail’s 2026 ranking of Canada’s Top Growing Companies, based on three-year revenue growth of 53%.
This marks the sixth consecutive year Knight has appeared on the list.
The company has over 50 product launches completed or planned across Canada and Latin America.
The ranking is based on an editorial process that includes an in-depth application and revenue requirements.

The big picture

Knight Therapeutics’ inclusion in The Globe and Mail’s Top Growing Companies list underscores its consistent growth trajectory in the pharmaceutical sector. The company’s focus on acquiring and commercializing pharmaceutical products in Canada and Latin America positions it well in a market increasingly driven by innovation and regional expansion. With over 50 product launches in the pipeline, Knight’s ability to execute these plans will be critical to sustaining its growth momentum.

What we're watching

Growth Sustainability: Whether Knight can maintain its 53% three-year revenue growth amid increasing competition in the pharmaceutical sector.
Product Launch Pace: The pace at which Knight can successfully launch its 50+ planned products across Canada and Latin America.
Market Expansion: How Knight’s strategic focus on Canada and Latin America will impact its market share and revenue growth.